CA Patent

CA1291036C — Nasal administration of drugs

Assigned to Fisons Corp · Expires 1991-10-22 · 35y expired

What this patent protects

ABSTRACT OF THE DISCLOSURE Compositions and methods for the nasal administration of drugs with reduced nasal irritation are disclosed.

USPTO Abstract

ABSTRACT OF THE DISCLOSURE Compositions and methods for the nasal administration of drugs with reduced nasal irritation are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
CA1291036C
Jurisdiction
CA
Classification
—
Expires
1991-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Fisons Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.